Literature DB >> 15504891

Nonisotopic, semiautomated plasmodium falciparum bioassay for measurement of antimalarial drug levels in serum or plasma.

Harald Noedl1, Paktiya Teja-Isavadharm, Robert Scott Miller.   

Abstract

A simple, nonisotopic, semiautomated bioassay for the measurement of antimalarial drug levels in plasma or serum based on the quantitation of histidine-rich protein II in malaria culture is presented. The assay requires only small sample volumes and was found to be highly sensitive and reproducible. The results closely paralleled those obtained with isotopic bioassays (R = 0.988, P < 0.001) and high-performance liquid chromatography-electrochemical detection (R = 0.978, P < 0.001).

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15504891      PMCID： PMC525391          DOI： 10.1128/AAC.48.11.4485-4487.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Histidine-rich protein II: a novel approach to malaria drug sensitivity testing.

Authors:  Harald Noedl; Walther H Wernsdorfer; Robert Scott Miller; Chansuda Wongsrichanalai
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Determination of the antimalarial arteether and its deethylated metabolite dihydroartemisinin in plasma by high-performance liquid chromatography with reductive electrochemical detection.

Authors:  V Melendez; J O Peggins; T G Brewer; A D Theoharides
Journal:  J Pharm Sci       Date:  1991-02       Impact factor: 3.534

Review 3.  Malaria drug-sensitivity testing: new assays, new perspectives.

Authors:  Harald Noedl; Chansuda Wongsrichanalai; Walther H Wernsdorfer
Journal:  Trends Parasitol       Date:  2003-04

4.  Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.

Authors:  N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1994-06       Impact factor: 2.184

5.  Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria.

Authors:  P Teja-Isavadharm; G Watt; C Eamsila; K Jongsakul; Q Li; G Keeratithakul; N Sirisopana; L Luesutthiviboon; T G Brewer; D E Kyle
Journal:  Am J Trop Med Hyg       Date:  2001-12       Impact factor: 2.345

6.  A bioassay for evaluating antimalarial activity and for measuring concentration in plasma.

Authors:  B Traore; E Lazaro; F Gay
Journal:  Trop Med Int Health       Date:  1997-10       Impact factor: 2.622

7.  Chloroquine bioassay using malaria microcultures.

Authors:  B M Kotecka; K H Rieckmann
Journal:  Am J Trop Med Hyg       Date:  1993-10       Impact factor: 2.345

8.  A bioassay for derivatives of qinghaosu (artemisinin).

Authors:  X Li; K Rieckmann
Journal:  Trop Med Parasitol       Date:  1992-09

9.  Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma.

Authors:  B M Kotecka; K H Rieckmann; T M E Davis; K T Batty; K F Ilett
Journal:  Acta Trop       Date:  2003-08       Impact factor: 3.112

10.  Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.

Authors:  Paktiya Teja-Isavadharm; James O Peggins; Thomas G Brewer; Nicholas J White; H Kyle Webster; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191
  10 in total
  11 in total

1.  Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.

Authors:  Phisit Khemawoot; David Saunders; Maneerat Rasameesoraj; Victor Melendez; Rawiwan Imerbsin; Colin Ohrt; Susan Fracisco; Paktiya Teja-Isavadharm
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from Gabon.

Authors:  Andrea Kreidenweiss; Benjamin Mordmüller; Sanjeev Krishna; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.

Authors:  Suwanna Chaorattanakawee; David L Saunders; Darapiseth Sea; Nitima Chanarat; Kritsanai Yingyuen; Siratchana Sundrakes; Piyaporn Saingam; Nillawan Buathong; Sabaithip Sriwichai; Soklyda Chann; Youry Se; You Yom; Thay Kheng Heng; Nareth Kong; Worachet Kuntawunginn; Kuntida Tangthongchaiwiriya; Christopher Jacob; Shannon Takala-Harrison; Christopher Plowe; Jessica T Lin; Char Meng Chuor; Satharath Prom; Stuart D Tyner; Panita Gosi; Paktiya Teja-Isavadharm; Chanthap Lon; Charlotte A Lanteri
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

4.  A novel bioassay model to determine clinically significant bisphosphonate levels.

Authors:  Mark A Scheper; Ashraf Badros; Andrew R Salama; Gary Warburton; Kevin J Cullen; Dianna S Weikel; Timothy F Meiller
Journal:  Support Care Cancer       Date:  2009-08-04       Impact factor: 3.603

5.  In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.

Authors:  Samuel L Nsobya; Moses Kiggundu; Sarah Nanyunja; Moses Joloba; Bryan Greenhouse; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

6.  Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.

Authors:  Stuart D Tyner; Chanthap Lon; Youry Se; Delia Bethell; Doung Socheat; Harald Noedl; Darapiseth Sea; Wichai Satimai; Kurt Schaecher; Wiriya Rutvisuttinunt; Mark M Fukuda; Suwanna Chaorattanakawee; Kritsanai Yingyuen; Siratchana Sundrakes; Panjaporn Chaichana; Piyaporn Saingam; Nillawan Buathong; Sabaithip Sriwichai; Soklyda Chann; Ans Timmermans; David L Saunders; Douglas S Walsh
Journal:  Malar J       Date:  2012-06-13       Impact factor: 2.979

7.  Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial.

Authors:  Delia Bethell; Youry Se; Chanthap Lon; Stuart Tyner; David Saunders; Sabaithip Sriwichai; Sea Darapiseth; Paktiya Teja-Isavadharm; Phisit Khemawoot; Kurt Schaecher; Wiriya Ruttvisutinunt; Jessica Lin; Worachet Kuntawungin; Panita Gosi; Ans Timmermans; Bryan Smith; Duong Socheat; Mark M Fukuda
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

8.  Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment.

Authors:  Jessica T Lin; Delia Bethell; Stuart D Tyner; Chanthap Lon; Naman K Shah; David L Saunders; Sabaithip Sriwichai; Phisit Khemawoot; Worachet Kuntawunggin; Bryan L Smith; Harald Noedl; Kurt Schaecher; Duong Socheat; Youry Se; Steven R Meshnick; Mark M Fukuda
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

9.  Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand.

Authors:  Nonlawat Boonyalai; Chatchadaporn Thamnurak; Piyaporn Sai-Ngam; Winita Ta-Aksorn; Montri Arsanok; Nichapat Uthaimongkol; Siratchana Sundrakes; Sorayut Chattrakarn; Chaiyaporn Chaisatit; Chantida Praditpol; Watcharintorn Fagnark; Kirakarn Kirativanich; Suwanna Chaorattanakawee; Pattaraporn Vanachayangkul; Paphavee Lertsethtakarn; Panita Gosi; Darunee Utainnam; Wuttikon Rodkvamtook; Worachet Kuntawunginn; Brian A Vesely; Michele D Spring; Mark M Fukuda; Charlotte Lanteri; Douglas Walsh; David L Saunders; Philip L Smith; Mariusz Wojnarski; Narongrid Sirisopana; Norman C Waters; Krisada Jongsakul; Jariyanart Gaywee
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.996

10.  Comparison of microbiological and high-performance liquid chromatographic methods for determination of clarithromycin levels in plasma.

Authors:  Farzaneh Lotfipour; Hadi Valizadeh; Somayeh Hallaj-Nezhadi; Morteza Milani; Parvin Zakeri-Milani
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.